Literature DB >> 7900530

Impetigo herpetiformis during pregnancy: case report and review of the literature.

Y Wolf1, A Groutz, I Walman, D Luxman, M P David.   

Abstract

A case of impetigo herpetiformis in pregnancy is reported together with a review of the literature. The patient was a 25-year-old primigravida with pregnancy-induced hypertension (PIH). At 35 weeks' gestation, the patient developed a severely pruritic pustular rash with fever and leukocytosis. The skin of the affected areas was biopsied and showed intraepidermal pustules with a neutrophilic infiltrate. Treatment commenced with intravenous fluids, oral prednisone, and steroid creams. Labor was induced, and a normal delivery of a healthy infant was effected, following which the patient's condition improved rapidly. The clinical and laboratory features were typical of impetigo herpetiformis as described in the literature. Impetigo herpetiformis is a rare, potentially serious skin disorder occurring particularly during pregnancy, and must be diagnosed early to allow prompt, aggressive treatment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7900530     DOI: 10.3109/00016349509008946

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  3 in total

1.  First trimester impetigo herpetiformis in multiparous female successfully treated with oral cyclosporine.

Authors:  Caroline J Shaw; Pensee Wu; Amir Sriemevan
Journal:  BMJ Case Rep       Date:  2011-05-12

Review 2.  Two case reports of generalized pustular psoriasis of pregnancy: Different outcomes.

Authors:  Aoibheann Flynn; Naomi Burke; Bridgette Byrne; Noreen Gleeson; Bairbre Wynne; Louise Barnes
Journal:  Obstet Med       Date:  2016-02-24

3.  Cyclosporine in the management of impetigo herpetiformis: a case report and review of the literature.

Authors:  Aikaterini Patsatsi; Theodoros D Theodoridis; Dimitrios Vavilis; Vasilios Tzevelekis; Aikaterini Kyriakou; Dimitrios Kalabalikis; Dimitrios Sotiriadis
Journal:  Case Rep Dermatol       Date:  2013-03-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.